Astrana Health, Inc. (NASDAQ:ASTH – Free Report) – Equities researchers at William Blair increased their Q3 2024 earnings per share (EPS) estimates for shares of Astrana Health in a note issued to investors on Tuesday, May 7th. William Blair analyst R. Daniels now anticipates that the company will earn $0.43 per share for the quarter, up from their previous estimate of $0.41. The consensus estimate for Astrana Health’s current full-year earnings is $1.65 per share. William Blair also issued estimates for Astrana Health’s Q1 2025 earnings at $0.36 EPS, Q2 2025 earnings at $0.39 EPS and FY2025 earnings at $1.48 EPS.
ASTH has been the topic of several other reports. Stifel Nicolaus reduced their target price on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Wednesday. Jefferies Financial Group initiated coverage on Astrana Health in a report on Monday, February 26th. They set a “buy” rating and a $50.00 price objective on the stock. Finally, Truist Financial upped their price objective on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a report on Friday, March 1st.
Astrana Health Price Performance
Shares of ASTH opened at $39.05 on Thursday. The firm has a market cap of $2.19 billion, a P/E ratio of 29.58, a P/E/G ratio of 1.20 and a beta of 1.12. The company has a quick ratio of 2.11, a current ratio of 2.11 and a debt-to-equity ratio of 0.42. Astrana Health has a one year low of $28.86 and a one year high of $45.71. The stock has a 50 day simple moving average of $40.12.
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). The business had revenue of $404.36 million during the quarter, compared to analyst estimates of $413.84 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The firm’s revenue was up 19.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.42 earnings per share.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
- Five stocks we like better than Astrana Health
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What Are the U.K. Market Holidays? How to Invest and Trade
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.